首页> 外文期刊>National Journal of Medical Research >Palliative Radiotherapy in the Management of Advanced Pediatric Malignancies
【24h】

Palliative Radiotherapy in the Management of Advanced Pediatric Malignancies

机译:姑息放疗治疗小儿晚期恶性肿瘤

获取原文
       

摘要

Purpose: To evaluate the role of palliative radiotherapy in the management of advanced pediatric malignancies. Methods: Patients coming to the department of radiotherapy S.M.S Hospital were included in the study. Out of 40 patients 36 pediatric patients were selected between Nov 2010 to Nov 2012. 4 Patients were excluded from the study. Inclusion Criteria (1) Advanced Pediatric Malignancy (2) Age 1 to 20 yrs (3) Consents of parents (4) Symptomatic Patients.Exclusion Criteria (1) Early stage Disease (2)Asymptomatic Patients(3)Age 20 yrs(4)No Consent All of theses 36 children received palliative external beam radiotherapy by cobalt 60. . The two dose schedules were used (1) 625cGy in 3 fractions (2) 30 Gy in 10 fractions. Results: There were 26 boys and 10 girls in the age group of 1 to 19 years, with a median age of 14 years (range of 1-19 years). Predominant symptoms were swelling, pain, bleeding, and weakness of limbs. The median duration of symptoms was 80 days (range of 4-40 days). The histological diagnosis was malignant round cell tumors (17); retinoblastoma (6); neuroblastoma (5); and Ewing's sarcoma (8). All patients presented with advanced stages of disease. Out of 36 patients 18 (50%) had disseminated disease at presentation. Some patients underwent surgery and chemotherapy and all patients received palliative radiotherapy. Three patients showed complete resolution, 18 patients showed good, while 14 patients had little, 1 did not have any relief in their symptoms. At the completion of treatment, 16 patients had partial response, 8 patients had progressive disease, 10 had stable disease and 2 patients had complete response. Conclusions: So the role of radiotherapy is very important as palliative modality in children with locally advanced lesions.
机译:目的:评估姑息性放疗在晚期小儿恶性肿瘤治疗中的作用。方法:研究纳入了S.M.S医院放射治疗科的患者。在2010年11月至2012年11月之间,从40名患者中选择了36名儿科患者。4名患者被排除在研究之外。入选标准(1)小儿恶性肿瘤(2)年龄1至20岁(3)父母同意(4)有症状的患者排除标准(1)早期疾病(2)无症状患者(3)20岁(4)没有同意所有这36名儿童均接受了60钴的姑息性体外束放射疗法。使用两种剂量方案(1)3个馏分的625cGy(2)10个馏分的30 Gy。结果:年龄段为1至19岁的男孩中有26名男孩和10名女孩,中位年龄为14岁(范围为1-19岁)。主要症状为肿胀,疼痛,出血和四肢无力。症状的中位持续时间为80天(范围为4-40天)。组织学诊断为恶性圆形细胞肿瘤(17);视网膜母细胞瘤(6);神经母细胞瘤(5);和尤因氏肉瘤(8)。所有患者均处于疾病晚期。在36名患者中,有18名(50%)在就诊时已传播疾病。一些患者接受了手术和化学疗法,所有患者都接受了姑息放疗。 3例患者显示完全消退,18例患者恢复良好,14例患者很少,1例症状没有缓解。治疗结束时,部分缓解16例,进行性疾病8例,疾病稳定10例,完全缓解2例。结论:因此,放疗作为局部晚期病变儿童的姑息疗法非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号